Volume Spike Investor

Human Genome Sciences, Inc. 9NASDAQ: HGSI) is surging on two bits of data which may be more round-about rather than direct on the company. First, there was some chatter of a potential takeover yesterday but that is common in biotech and related stocks from time to time. Second, the Obama administration has pledged to help companies get the H1N1 flu vaccine available in larger doses and earlier than many of the target dates. At 8:27 AM EST we have shares up over 7% at $18.40 on over 160,000 shares. This also marks a 52-week high and multi-year high. -JON OGG